Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $11.7 million.

  • AdaptHealth's Net Cash Flow fell 6135.82% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.8 million, marking a year-over-year decrease of 14501.44%. This contributed to the annual value of $32.6 million for FY2024, which is 568.7% up from last year.
  • According to the latest figures from Q3 2025, AdaptHealth's Net Cash Flow is $11.7 million, which was down 6135.82% from $15.0 million recorded in Q2 2025.
  • AdaptHealth's Net Cash Flow's 5-year high stood at $158.5 million during Q3 2021, with a 5-year trough of -$187.0 million in Q4 2021.
  • Moreover, its 5-year median value for Net Cash Flow was $9.6 million (2024), whereas its average is -$1.0 million.
  • Within the past 5 years, the most significant YoY rise in AdaptHealth's Net Cash Flow was 28255.24% (2023), while the steepest drop was 899127.63% (2023).
  • AdaptHealth's Net Cash Flow (Quarter) stood at -$187.0 million in 2021, then soared by 65.53% to -$64.5 million in 2022, then surged by 132.56% to $21.0 million in 2023, then crashed by 54.42% to $9.6 million in 2024, then increased by 22.58% to $11.7 million in 2025.
  • Its last three reported values are $11.7 million in Q3 2025, $15.0 million for Q2 2025, and -$56.1 million during Q1 2025.